Assessing Tumor Progression in Neuroendocrine Cancer Patients
Thermo Fisher Scientific
Thermo Fisher announces FDA-clearance of first-to-market automated assay
Neuroendocrine Tumors
Phase 3 Trial for Neuroendocrine Tumor Treatment Shows Promise
The Alliance for Clinical Trials in Oncology
The safety profile of cabozantinib observed in the trial was consistent with its known safety profile
Neuroendocrine Tumors: Choosing the Best Treatment
University of Geneva
Which treatments for which patient?